0.4% Lidocaine Hydrochloride and 5% Dextrose Injection 50 mg (Dextrose SOLUTION) 50 MG

0.4% Lidocaine Hydrochloride and 5% Dextrose Injection 50 MG is a combination solution used for pain relief and fluid replenishment. This intravenous solution is manufactured by Baxter Corporation in Canada.

Strength

50 MG

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

0.4% Lidocaine Hydrochloride and 5% Dextrose Injection 50 MG is commonly used for pain management and to provide hydration. Lidocaine is a local anesthetic that helps to numb areas of the body, while dextrose provides a source of energy. This combination is often used in medical settings to address both pain and fluid needs.

Side Effects

The effects of 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection 50 MG typically include pain relief and increased energy levels due to the dextrose component. Some individuals may experience temporary numbness or tingling in the area where the solution is administered.

Precautions & Warnings

It is important to use 0.4% Lidocaine Hydrochloride and 5% Dextrose Injection 50 MG under the supervision of a healthcare professional. Always follow the prescribed guidelines and inform your healthcare provider of any allergies or medical conditions before use.

Avoid Interactions

This injection may interact with other medications, including those that affect the central nervous system or blood sugar levels. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions.

Frequently Asked Questions

This injection is used for pain relief and fluid replenishment, combining the anesthetic properties of lidocaine with the energy-providing effects of dextrose.

This solution is administered intravenously, typically in a medical setting under the supervision of a healthcare professional.

Common effects include pain relief and increased energy levels, with some individuals experiencing temporary numbness or tingling.

Yes, it is important to use this injection under the guidance of a healthcare provider and to inform them of any allergies or medical conditions.

Yes, this injection may interact with medications that affect the central nervous system or blood sugar levels, so it is important to discuss all current medications with a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.